3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
18
Prostatic Neoplasms
16
Glioma
13
Neoplasm Metastasis
11
Carcinoma, Non-Small-Cell Lung
11
Breast Neoplasms
11
Urinary Bladder Neoplasms
10
Pancreatic Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Multiple Myeloma
9
Mouth Neoplasms
9
Lymphoma
9
Colorectal Neoplasms
8
Carcinoma, Renal Cell
8
Ovarian Neoplasms
7
Oropharyngeal Neoplasms
7
Melanoma
7
Laryngeal Neoplasms
7
Carcinoma, Hepatocellular
7
Carcinoma
7
Wilms Tumor
6
Neuroblastoma
6
Nasopharyngeal Carcinoma
6
Medulloblastoma
6
Glioblastoma
6
Fallopian Tube Neoplasms
6
Triple Negative Breast Neoplasms
5
Sarcoma
5
Rhabdoid Tumor
5
Osteosarcoma
5
Interventions
Gemcitabine
6
Mitomycin
4
erdafitinib
3
viscum album peptide
1
pirarubicin
1
hydroxycamptothecinum
1
durvalumab
1
Watchful Waiting
1
Transurethral Resection of Bladder
1
Magnetic Resonance Spectroscopy
1
Injections
1
Epirubicin
1
Cystoscopy
1
BCG Vaccine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Magnetic Resonance Spectroscopy
×
30 days
×
Clear all
NCT07000084
2026-06-02
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3
Recruiting
330 enrolled